Sarepta Therapeutics, which develops precision genetic medicines for DMD, trades on the Nasdaq and is headquartered in Cambridge.
3 reports, 3 independent
Updated Thu 00:00
No new developments lately
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sarepta Therapeutics, which develops precision genetic medicines for DMD, trades on the Nasdaq and is headquartered in Cambridge.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sarepta Therapeutics
biopharmaceutical company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
- DMD
Related events
- Praxis Precision Medicines listed its shares on the Nasdaq stock exchange on July 17, 2026.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.
- DiaMedica Therapeutics, Inc. shares were traded on the Nasdaq exchange on October 14, 2026.
- Janux Therapeutics, Inc. was listed on the Nasdaq stock exchange on July 28, 2026.
- Ovid Therapeutics stock traded on the Nasdaq exchange on July 18, 2026.
Coverage
Newest first; wire copies grouped- tickerreport.com
- themarketsdaily.com
- dailypolitical.comAnalysts’ Weekly Ratings Changes for Sarepta Therapeutics (SRPT)